Tarsus Pharmaceuticals
TARS
TARS
215 hedge funds and large institutions have $2.67B invested in Tarsus Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 65 increasing their positions, 91 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 203 → 215 (+12)
3.47% less ownership
Funds ownership: 109.8% → 106.33% (-3.5%)
29% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 91
Holders
215
Holding in Top 10
6
Calls
$3.14M
Puts
$1.13M
Top Buyers
| 1 | +$74.3M | |
| 2 | +$23.2M | |
| 3 | +$15.9M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$14.9M |
| 5 |
CFM
Capricorn Fund Managers
London,
United Kingdom
|
+$14.3M |
Top Sellers
| 1 | -$22.8M | |
| 2 | -$22M | |
| 3 | -$21.9M | |
| 4 |
JGC
J. Goldman & Co
New York
|
-$19M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
-$18.4M |
